<HashMap><database>biostudies-literature</database><scores/><additional><submitter>Abdullah M</submitter><funding>Bill and Melinda Gates Foundation</funding><pagination>e0274718</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC9714835</full_dataset_link><repository>biostudies-literature</repository><omics_type>Unknown</omics_type><volume>17(12)</volume><pubmed_abstract>Developing countries have been facing difficulties in reaching out to low-income and underserved communities for COVID-19 vaccination coverage. The rapidity of vaccine development caused a mistrust among certain subgroups of the population, and hence innovative approaches were taken to reach out to such populations. Using a sample of 1760 respondents in five low-income, informal localities of Islamabad and Rawalpindi, Pakistan, we evaluated a set of interventions involving community engagement by addressing demand and access barriers. We used multi-level mixed effects models to estimate average treatment effects across treatment areas. We found that our interventions increased COVID-19 vaccine willingness in two treatment areas that are furthest from city centers by 7.6% and 6.6% respectively, while vaccine uptake increased in one of the treatment areas by 17.1%, compared to the control area. Our results suggest that personalized information campaigns such as community mobilization help to increase COVID-19 vaccine willingness. Increasing uptake however, requires improving access to the vaccination services. Both information and access may be different for various communities and therefore a "one-size-fits-all" approach may need to be better localized. Such underserved and marginalized communities are better served if vaccination efforts are contextualized.</pubmed_abstract><journal>PloS one</journal><pubmed_title>Community engagement to increase vaccine uptake: Quasi-experimental evidence from Islamabad and Rawalpindi, Pakistan.</pubmed_title><pmcid>PMC9714835</pmcid><funding_grant_id>INV-025171</funding_grant_id><pubmed_authors>Khan AA</pubmed_authors><pubmed_authors>Safdar RM</pubmed_authors><pubmed_authors>Abdullah M</pubmed_authors><pubmed_authors>Ahmad T</pubmed_authors><pubmed_authors>Kazmi T</pubmed_authors><pubmed_authors>Sultan F</pubmed_authors><pubmed_authors>Afzal S</pubmed_authors></additional><is_claimable>false</is_claimable><name>Community engagement to increase vaccine uptake: Quasi-experimental evidence from Islamabad and Rawalpindi, Pakistan.</name><description>Developing countries have been facing difficulties in reaching out to low-income and underserved communities for COVID-19 vaccination coverage. The rapidity of vaccine development caused a mistrust among certain subgroups of the population, and hence innovative approaches were taken to reach out to such populations. Using a sample of 1760 respondents in five low-income, informal localities of Islamabad and Rawalpindi, Pakistan, we evaluated a set of interventions involving community engagement by addressing demand and access barriers. We used multi-level mixed effects models to estimate average treatment effects across treatment areas. We found that our interventions increased COVID-19 vaccine willingness in two treatment areas that are furthest from city centers by 7.6% and 6.6% respectively, while vaccine uptake increased in one of the treatment areas by 17.1%, compared to the control area. Our results suggest that personalized information campaigns such as community mobilization help to increase COVID-19 vaccine willingness. Increasing uptake however, requires improving access to the vaccination services. Both information and access may be different for various communities and therefore a "one-size-fits-all" approach may need to be better localized. Such underserved and marginalized communities are better served if vaccination efforts are contextualized.</description><dates><release>2022-01-01T00:00:00Z</release><publication>2022</publication><modification>2026-03-16T08:12:34.015Z</modification><creation>2025-04-05T14:41:08.837Z</creation></dates><accession>S-EPMC9714835</accession><cross_references><pubmed>36454856</pubmed><doi>10.1371/journal.pone.0274718</doi></cross_references></HashMap>